Table of Contents
For years, women have been told to fear hormone therapy. That fear came mostly from a bold, scary label on estrogen and progesterone medications called a “black box warning.”
That warning said hormone therapy could raise the risk of heart disease, breast cancer, stroke, and even dementia — and it stopped a lot of women from getting help for menopause symptoms that were affecting their sleep, mood, energy, and weight.
But now, there’s good news.
The FDA has officially announced that it’s removing the black box warning from most hormone therapy products.
This change recognizes what new research has shown for years — that when hormone therapy is prescribed appropriately and started near the time of menopause, it can be safe, effective, and life-changing for many women.¹ ²
Why the FDA Changed Its Mind
Back in 2002, a big research study called the Women’s Health Initiative (WHI) made headlines when it linked hormone therapy to certain health risks. Unfortunately, that study included mostly older women — many of whom were years past menopause — and the results were misunderstood.
Since then, more research has shown a very different story:
Women who begin hormone therapy within 10 years of menopause (typically in their 40s or 50s) may actually experience health benefits, including better bone, heart, and metabolic health.²
The FDA’s new decision reflects this updated science.
What This Means for You
This change doesn’t mean hormone therapy is for everyone — but it does mean we can talk about it more openly and without outdated fear.
Hormones play a role in almost everything:
- Weight and metabolism
- Sleep and recovery
- Mood and focus
- Heart and bone health
So if you’ve been struggling with fatigue, weight gain, or that feeling of being “off” during perimenopause or menopause — this may be an option worth exploring.
At PharmAssist, we take a personalized approach. That means:
- Reviewing your health history and lab work
- Creating a treatment plan just for you
- Monitoring your progress closely for safety and results
Safety Still Comes First
Even though the “black box” is going away, hormone therapy still requires the right provider and the right plan.
For example, if you still have a uterus, we’ll use protective strategies like balancing estrogen with progesterone to lower certain risks.
The key is individualization — not fear, not guesswork, and definitely not a one-size-fits-all approach.
The Bottom Line
This is a big win for women’s health — and for every woman who’s been told to “just deal with it.”
The FDA’s update reflects what evidence and experience have been saying all along:
When used correctly and monitored by a qualified clinician, hormone therapy can safely help women feel stronger, clearer, and more like themselves again.
If you’ve been curious about hormone therapy but hesitant because of old warnings — now’s the perfect time to talk about it.
References
- U.S. Department of Health & Human Services / FDA. “FDA Initiates Removal of ‘Black Box’ Warnings from Menopausal Hormone Replacement Therapy Products.” November 2025.
- Makary MA et al. “Updated Labeling for Menopausal Hormone Therapy.” JAMA. 2025.
